Direxion Daily S&P Biotec... (LABU)
NYSEArca: LABU
· Precio en tiempo real · USD
309.60
+19.62 (6.77%)
Al cierre: Aug 19, 2026, 3:59 PM
Direxion Daily S&P Biotech Bull 3X Shares (LABU) ETF Price, Holdings & Analysis
6.77% (1D)
| Precio de compra | 336 |
| Capitalización de mercado | n/a |
| AUM | 494.37M |
| NAV | 290.08 |
| Beta | 3.26 |
| EPS (ttm) | n/a |
| Relación PE (ttm) | n/a |
| Acciones en circulación | n/a |
| Fecha de inicio | May 28, 2015 |
| Precio de venta | 339.6 |
| Volumen | 711,371 |
| Volumen medio (20D) | 518,719 |
| Abierto | 318.50 |
| Cierre anterior | 289.98 |
| Rango del día | 314.50 - 341.91 |
| Rango de 52 semanas | 66.00 - 341.93 |
| Participaciones | n/a |
| Relación de gastos | 0.96% |
Acerca de LABU
The fund, under normal circumstances, invests at least 80% of its net assets in financial instruments, such as swap agreements, securities of the index, and ETFs that track the index, that, in combination, provide 3X daily leveraged exposure to the index, consistent with the fund's investment objective. The index is designed to measure the performance of the biotechnology sub-industry based on the Global Industry Classification Standards ("GICS"). The fund is non-diversified.
Clase de activo Equity
Símbolo bursátil LABU
Fecha de inicio May 28, 2015
Proveedor Direxion Funds
Sitio web Página de inicio del fondo
Intercambio NYSEArca
Las 10 principales participaciones 3.23% de activos
| Nombre | Símbolo | Peso |
|---|---|---|
| Apogee Therapeutics ... | APGE | 1.16% |
| Oruka Therapeutics I... | ORKA | 1.07% |
| Dianthus Therapeutic... | DNTH | 1.00% |
Dividendos Rendimiento de dividendos 0.43%
| Ex-Dividendo | Cantidad | Fecha de pago |
|---|---|---|
| Dec 23, 2025 | $0.9100 | n/a |
| Sep 23, 2025 | $0.1030 | n/a |
| Jun 24, 2025 | $0.2190 | n/a |
| Mar 25, 2025 | $0.1070 | n/a |
| Jun 25, 2024 | $0.1500 | n/a |
